Ependymoma Recruiting Phase 1 Trials for Ibrutinib (DB09053)

Also known as: Brain Ependymoma / Ependymoma of Brain / Ependymomas / Ependymoma (morphologic abnormality) / Ependymoma (disorder) / Ependymoma of brain (disorder)

IndicationStatusPhase
DBCOND0017183 (Ependymoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTreatment